Expanded non-invasive prenatal screening for chromosomal conditions across chromosomes 1–22, including trisomy 21, 18, and 13, with sex chromosome screening and fetal sex reporting.
Available from 10 weeks of pregnancy, this simple blood test provides broader early insights into your pregnancy.
- Trisomy 21 (Down syndrome)
- Trisomy 18 (Edwards syndrome)
- Trisomy 13 (Patau syndrome)
- Monosomy X (Turner syndrome)
- XXX (Triple X syndrome)
- XXY (Klinefelter syndrome)
- XYY (Jacobs syndrome)
- Chromosome 1–22 aneuploidy screening
- Fetal sex reporting
